Cancer BiologybioRxiv
Targeted mutation detection in breast cancer using MammaSeqTM
N. G. Smith, R. Gyanchandani, G. T. Gurda…·A. V. Lee
The paper develops MammaSeq, a targeted NGS panel for detecting clinically actionable mutations in breast cancer, showing it identifies actionable variants in 48% of solid tumors and 29% of cfDNA samples.
DOI 10.1186/s13058-019-1102-7